AngioDynamics (ANGO) Projected to Post Earnings on Tuesday

AngioDynamics (NASDAQ:ANGO) is anticipated to release its Q4 2025 earnings data before the market opens on Tuesday, July 15th. Analysts expect AngioDynamics to post earnings of ($0.13) per share and revenue of $74.26 million for the quarter.

AngioDynamics Stock Performance

Shares of NASDAQ ANGO opened at $9.32 on Monday. The firm’s 50 day moving average price is $9.87 and its 200-day moving average price is $10.08. The company has a market cap of $378.49 million, a PE ratio of -9.23 and a beta of 0.60. AngioDynamics has a 52-week low of $5.82 and a 52-week high of $13.50.

Analyst Ratings Changes

Separately, HC Wainwright reiterated a “buy” rating and issued a $16.00 target price (up previously from $15.00) on shares of AngioDynamics in a research note on Monday, April 7th.

Institutional Inflows and Outflows

An institutional investor recently raised its position in AngioDynamics stock. Jane Street Group LLC boosted its stake in shares of AngioDynamics, Inc. (NASDAQ:ANGO) by 267.1% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 46,803 shares of the medical instruments supplier’s stock after purchasing an additional 34,054 shares during the period. Jane Street Group LLC owned about 0.12% of AngioDynamics worth $439,000 at the end of the most recent reporting period. Institutional investors own 89.43% of the company’s stock.

AngioDynamics Company Profile

AngioDynamics, Inc, a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium.